Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Incyte
Incyte
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Innovent, Incyte sign collaboration deal for three clinical-stage product candidates
Pharmaceutical Business Review
Mon, 12/17/18 - 09:02 am
Incyte
Innovent Biologics
pemigatinib
itacitinib
parsaclisib
5 Top Drug/Biotech Merger & Acquisition Targets for 2019
Yahoo/Zacks.com
Mon, 12/10/18 - 09:50 am
M&A
Biomarin
Vertex Pharmaceuticals
Incyte
Alnylam
Alexion
FDA Grants Priority Review for Ruxolitinib (Jakafi) for Acute Graft-Versus-Host Disease
CP Wire
Thu, 10/25/18 - 09:52 am
FDA
Incyte
Novartis
Jakavi
Jakafi
graft vs host disease
FDA Grants Priority Review for Ruxolitinib (Jakafi) for Acute Graft-Versus-Host Disease
Thu, 10/25/18 - 09:35 am
Incyte
graft vs host disease
Novartis
Jakafi
Agenus sells cut of Incyte, Merck milestone streams
Fierce Biotech
Fri, 09/21/18 - 09:55 am
Agenus
Incyte
Merck
Xoma
Incyte preps Jakafi expansion into graft-versus-host disease
Biopharma Dive
Thu, 06/21/18 - 11:00 pm
Incyte
Jakafi
graft vs host disease
Eli Lilly’s Arthritis Drug Approved at Lower Dose with Boxed Warning
Xconomy
Fri, 06/1/18 - 10:36 pm
Eli Lilly
Incyte
FDA
rheumatoid arthritis
olumiant
baricitinib
3 Biotechs With Huge FDA Decisions in June
Motley Fool
Thu, 05/31/18 - 10:00 pm
biotech
Array Biopharma
encorafenib
binimetinib
GW Pharma
Epidiolex
Incyte
olumiant
IDO Don’ts: After Immunotherapy Failure, Experts Say Slow Down
Xconomy
Thu, 05/31/18 - 08:17 pm
ASCO
oncology
IDO inhibitors
Incyte
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
Yahoo/Benzinga
Mon, 05/28/18 - 02:14 pm
ASCO 2018
European Society of Cardiology
TherapeuticsMD
Abiomed
Incyte
Bluebird Bio
Celgene
Syndax
Loxo Oncology
Exelixis
Karyopharm
Endocyte
Celldex Therapeutics
Jounce Therapeutics
Bristol-Myers Squibb
Nektar
Incyte wipes out late-phase epacadostat program after pivotal failure of Keytruda combination
Fierce Biotech
Wed, 05/2/18 - 09:55 am
Incyte
epacadostat
Keytruda
IDO inhibitors
FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses
Xconomy
Mon, 04/23/18 - 11:15 pm
Eli Lilly
FDA
advisory panels
rheumatoid arthritis
baricitinib
Incyte
Big Week Ahead for Eli Lilly: Here's What to Look For
Motley Fool
Sun, 04/22/18 - 12:12 pm
Eli Lilly
earnings
FDA
Incyte
olumiant
rheumatoid arthritis
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Fri, 04/20/18 - 12:45 pm
Incyte
TG Therapeutics
Cara Therapeutics
CR845
opioids
ublituximab
leukemia
olumiant
rheumatoid arthritis
[video]Why One Drug Flop Tanked Incyte's Stock
Motley Fool
Thu, 04/12/18 - 10:58 pm
Incyte
epacadostat
Incyte's Horrible News Derails a Promising Class of Cancer Drugs
Motley Fool
Fri, 04/6/18 - 07:43 pm
Incyte
Merck
epacadostat
IDO inhibitors
Roche
NewLink Genetics
How a Biotech Bummer Sent Nektar Therapeutics Stock South Today
Motley Fool
Fri, 04/6/18 - 07:41 pm
Nektar Therapeutics
Incyte
Merck
NKTR-214
Bristol-Myers Squibb
Incyte's stock plunges, Merck shares fall after disappointing study results of melanoma treatment
Marketwatch
Fri, 04/6/18 - 09:51 am
Incyte
Merck
melanoma
epacadostat
Keytruda
clinical trials
metastatic melanoma
3 Biotechs That Could Get Big Boosts in April
Motley Fool
Wed, 03/28/18 - 10:02 am
biotech
GW Pharma
Epidiolex
Incyte
olumiant
baricitinib
Neurocrine Biosciences
Elagolix
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »